News Gist .News

Articles | Politics | Finance | Stocks | Crypto | AI | Technology | Science | Gaming | PC Hardware | Laptops | Smartphones | Archive

Philip Morris Weighs Cigar Sale Amid Smoke-Free Shift

Philip Morris International Inc. is considering selling its U.S. cigar business as part of its broader strategy to pivot towards smoke-free products. The company is reportedly seeking over $1 billion for the cigar division, which was acquired through the recent $16 billion purchase of Swedish Match AB. This move aligns with Philip Morris's goal to reduce its reliance on traditional tobacco products, with a target of smoke-free items making up two-thirds of sales by 2030.

See Also

Rio Tinto Scraps Plans to Raise Up to $5 Billion in Share Sale Δ1.73

Rio Tinto Group has scrapped plans to raise as much as $5 billion in a share sale following pushback from investors, people with knowledge of the matter said. The decision comes after the company had floated the possibility of an equity offering in recent investor meetings, citing a need to rebalance its share register between UK and Australian investors. This move suggests that Rio Tinto is prioritizing internal financing over external capital raises.

Business News Roundup Faces Financial Dilemmas, Regulatory Challenges, and Competitive Pressures Δ1.73

Consumer Reports has released its list of the 10 best new cars to buy in 2025, highlighting vehicles with strong road test scores and safety features. The announcement comes as Eli Lilly & Co. is expanding its distribution of weight-loss drug Zepbound at lower prices, while Target is scaling back its DEI efforts amidst declining store visits. Meanwhile, Costco's luxury goods segment continues to grow, and Apple has secured President Trump's backing for its new investment plan.

Saudi Aramco Exploring Initial Bid for BP's Castrol Unit, Source Says Δ1.72

Saudi Aramco is in the early stages of considering a potential bid for BP's lubricant business Castrol, according to a person with knowledge of the matter. The Saudi oil giant's interest comes as BP reviews its Castrol business, aiming to generate $20 billion in divestments by 2027. A successful acquisition could help Aramco expand its presence in the global lubricants market.

Novo Nordisk to Sell Wegovy for $499 a Month to Cash-Paying US Customers Δ1.72

Novo Nordisk has announced that it will begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, marking a significant shift in the competitive dynamic of the U.S. obesity drug market. This move comes as rival Eli Lilly has cut the price for its weight-loss drug Zepbound and expanded its direct-to-consumer sales through its website. The Danish drugmaker will also offer home delivery for Wegovy, which can cost patients over $1,000 a month without insurance coverage.

Wall Street's Top Analyst Calls Downgrade Upgrades Δ1.72

Walgreens downgraded by Deutsche Bank to Sell from Hold with a price target of $9, as reports of a potential take-private deal from Sycamore Partners are seen as overly optimistic and complicated to implement. Cava Group upgraded to Overweight from Neutral by Piper Sandler, citing the company's secular growth in fast casual and its strategic initiatives for 2025. The upgrade suggests that investors should consider the trend towards founder-led companies reclaiming control and potentially setting a precedent for similar brands.

Poundland Could Be Put Up for Sale as Taxes Rise, Owner Says Δ1.72

The UK's largest discount retailer, Poundland, is facing significant financial pressure due to rising tax costs, with its owner Pepco Group considering a potential sale of the business. The discount chain has seen sales decline in recent months, and the upcoming tax changes will add further pressure on its cost base. As part of its plans, Pepco Group is looking at ways to separate itself from Poundland and focus on its more profitable higher clothing and general merchandise ranges.

Saudi Aramco Exploring Initial Bid for BP's Castrol Unit, Source Says Δ1.71

BP's lubricant business Castrol is expected to be worth $6 billion to $8 billion, according to analyst Ashley Kelty. The business has been put up for sale as part of a strategic review by the company. BP has underperformed peers and faced increasing pressure to change strategy after activist investor Elliott Investment Management built a 5% stake in the company.

3 High-Yield Dividend Stocks to Buy Now and Hold Forever Δ1.71

Investors looking for long-term passive income opportunities may find Realty Income, Target, and Philip Morris International to be attractive dividend stocks according to Fool.com contributors. Realty Income, a REIT with a strong track record, offers a reliable monthly dividend, while Target, despite recent struggles, provides a higher dividend yield and growth potential compared to competitors. Philip Morris International's strong dividend history further solidifies it as a solid investment choice for those seeking consistent returns.

Shell Mulls Sale of European, US Chemicals Assets, WSJ Reports Δ1.71

Shell is considering a potential sale of its chemicals assets in Europe and the United States, as it aims to simplify its operations and focus on its core businesses. The energy group has hired Morgan Stanley to conduct a strategic review of its chemicals operations, which are expected to be significantly impacted by lower seasonal demand. Shell's trading in its chemicals and oil products division is expected to decline quarter-on-quarter due to reduced seasonal demand.

Prada Profit Surges, Declines to Comment on Possible Versace Bid Δ1.71

Prada's reported 21% growth in operating profit last year, in line with analysts' forecasts, amid speculation about a potential acquisition of smaller rival Versace. The group's net revenues reached 5.43 billion euros ($5.72 billion) in 2024, exceeding expectations and defying the slowdown in luxury demand. Prada's cautious approach to discussing its interests in Versace suggests that the company is biding its time before making a move.

Walgreens to Be Taken Private in $10 Billion Buyout by Sycamore Δ1.71

Walgreens Boots Alliance will be taken private by private equity firm Sycamore Partners in a $10 billion deal, ending nearly a century of public trading for the second-largest U.S. pharmacy chain. The acquisition reflects Walgreens' struggles with declining prescription margins, increasing debt, and competition from bigger stores. The purchase price represents a 90% drop from the company's $100 billion value in 2015.

Walgreens Acquisition Could Spark Consolidation in Healthcare Industry Δ1.71

Sycamore Partners' potential buyout of Walgreens Boots Alliance Inc. could lead to a significant shift in the pharmacy retailer's business segments, potentially sparking consolidation in the healthcare industry as private credit lenders and banks vie for financing opportunities. The acquisition plans involve splitting up Walgreens into separate businesses, which could impact the company's operational capacity and strategic direction. Private equity firms have a history of restructuring companies through acquisitions.

Seven & I in Talks with Couche-Tard over Store Sales for Merger Deal Δ1.71

Seven & i Holdings has initiated discussions with Alimentation Couche-Tard over a potential store sale plan that would pave the way for Couche-Tard's $47 billion takeover bid. The proposed divestiture process would involve mapping out the viability of selling off U.S. stores, with potential buyers identified and assessed. If successful, this could provide regulatory approval for Couche-Tard to complete its acquisition of Seven & i Holdings.

Walgreens Stock Has 'Run Too Far' On Deal Optimism, Analysts Say Δ1.71

Walgreens stock has fallen amid new details about a potential sale, with analysts warning that deal speculation has driven prices too high. Shares of the pharmacy group plummeted more than 5% as investors reassessed the prospects of a sale, citing concerns about complexity and valuation. The company's turnaround plan, which includes store closures and investment shifts, is expected to impact its performance in the short term.

Shell Mulls Sale of European, US Chemicals Assets, WSJ Reports Δ1.70

The energy group has hired Morgan Stanley to conduct a strategic review of its chemicals operations, the report said. Shell declined to comment. Morgan Stanley did not immediately respond to a request for comment outside regular business hours. The review is in its early stages and Shell has not yet made any definitive decisions regarding a potential sale, the Journal reported, adding that one of the assets included in the review was Shell's Deer Park facility in Texas. Last year Shell sold its refining and chemicals hub in Singapore, one of the world's largest.

Walgreens Stock Just Crashed 5.4% -- Here's the Shocking Reason Investors Are Panicking Δ1.70

Walgreens Boots Alliance experienced a decline of 5.4% following Deutsche Bank's decision to downgrade the stock from Hold to Sell, accompanied by a reduction in the price target to $9 from $11. Analyst George Hill expressed skepticism regarding the potential buyout by Sycamore Partners, describing it as "incredibly complicated" and unlikely to offer a premium over the current share price. The proposed deal is plagued by challenges within Walgreens' core U.S. business, including substantial debt, opioid-related liabilities, and a pending $2.7 billion IRS tax dispute.

Spanish Fashion Co Mango's Sales Rise 8% in 2024 Δ1.70

Mango reported an 8% increase in sales for 2024, reaching 3.33 billion euros, largely driven by its international expansion efforts, particularly in the United States. The company, now focusing on premium partywear, saw net profits soar by 27% and gross margins hit 60.7%, reflecting its successful strategy against competitors like Zara. With plans to expand its U.S. footprint by opening over 60 new stores by 2025, Mango aims to reach 4 billion euros in sales by 2026.

BITB Sep 2025 43.000 Call Price Sets Stage for Investor Uncertainty Δ1.70

The sale of the KAYALI fragrance brand to co-founder Mona Kattan and General Atlantic marks a shift in the beauty industry, where founder-led companies are reclaiming control from outside investors. This move is part of a broader trend that could impact the long-term strategic direction and innovation within the sector. The outcome of this restructuring will be closely watched as it sets a precedent for similar brands.

Blackstone Out of Race for India's Haldiram's over Valuation Concerns Δ1.70

Haldiram's snacks business is estimated to hold a near 13% share of India's $6.2 billion savoury snacks market, with valuation being a key sticking point in the deal talks between Haldiram's and Blackstone. The private equity investor had initially wanted around a 15% stake at a valuation of roughly $8 billion, but negotiations ultimately failed to bridge the gap. Rival bidder Temasek remains in the race to acquire a minority stake in the business.

Macy's Misses Mark on Sales Growth and Warns on Profits as Trump Tariffs Linger Δ1.70

Macy's has reported a fourth-quarter adjusted earnings per share of $1.80, beating analysts' estimates of $1.54, but same-store sales only grew 0.2%, missing the Street's estimate of 1.23% growth. The company's full-year revenue projection of $21 billion to $21.4 billion is below last year's $22.29 billion and misses estimates of $21.66 billion. Investors will be closely watching guidance and earnings call commentary as tariff concerns loom.

Best Buy Warns of Potential Price Increases as Fresh US Tariffs Roll In Δ1.70

Best Buy has issued a warning to American shoppers about potential price increases due to the implementation of new tariffs on imports from Mexico and Canada, which took effect on Tuesday. The company, which relies heavily on Chinese goods, expects fiscal year 2026 comparable sales to be in the range of flat to up 2%, largely below analysts' average expectations of a 1.71% rise. Shares of Best Buy reversed earlier gains to be down 1.3% in premarket trading as the pain from tariffs overshadowed a surprise rise in comparable sales during the holiday quarter.

Jack Daniel's Maker Says Canada Pulling US Alcohol Off Shelves 'Worse Than Tariff' Δ1.70

Brown-Forman's CEO Lawson Whiting expressed that Canadian provinces removing American liquor from their shelves is a more severe reaction than tariffs imposed by the U.S. government, describing it as a "disproportionate response." While Canada accounted for a mere 1% of Brown-Forman's total sales, the company's leadership is monitoring the situation closely, especially with an eye on Mexico, which represents a larger portion of their market. The ongoing tensions and retaliatory measures highlight the complexities of international trade relations and their impact on consumer behavior.

Cramer Weighs In on LLY: A Pharma Giant's Price Cut Amid Rising Regulatory Scrutiny Δ1.70

Eli Lilly and Company (NYSE:LLY) has recently announced a price cut for its insulin products, which is expected to have a significant impact on the company's revenue. The move comes amidst increasing regulatory scrutiny of pharmaceutical companies' pricing practices. As Jim Cramer sees it, the cut will likely boost LLY's sales, but the long-term implications of this move remain uncertain.

The Rise of the Buy Now, Pay Later Industry Is Redefining Personal Debt Δ1.69

Hilary Martin, an Australian buyer's agent, has revealed that her biggest month brought in $180,000 in earnings, despite requiring only a few weeks of training to get started. The industry is experiencing an "exciting" shift due to changes in interest rates and property prices, with buyers' agents earning commissions from each home sold. Martin's agency has seen high demand for its services, allowing it to capitalize on the growing trend of buy now, pay later models.

Target Faces Near-Term Profit Squeeze From Tariffs, Cautious Spending Δ1.69

Target's forecast full-year comparable sales came below estimates after a discount-driven holiday quarter results beat, and said uncertainty around tariffs as well as consumer spending would weigh on first-quarter profits. The company joined Walmart and Best Buy in raising caution about their expectations for the year as sticky inflation and tariffs temper demand. Target expects comparable sales to be flat in the year through January 2026, compared with analysts' average estimate of 1.86% growth.